CoChat

Empagliflozin influences blood viscosity and wall shear stress in subjects with type 2 diabetes mellitus compared with incretin-based therapy

Open access

The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Cardiovascular protection following empagliflozin therapy is not entirely attributable to the glucose lowering effect. Increased hematocrit might influence the shear stress that is the main force acting on the endothelium, regulating its anti-atherogenic function. OBJECTIVE: We designed the study with the aim of investigating the effect of empagliflozin on blood viscosity and shear stress in the carotid arteries. A secondary endpoint was the effect of empagliflozin on carotid artery wall thickness. METHODS: The study was a non-randomized, open, prospective cohort study including 35 type 2 diabetic outpatients who were offered empagliflozin or incretin-based therapy (7 liraglutide, 8 sitagliptin) in combination with insulin and metformin. Blood viscosity, shear stress and carotid wall thickness were measured at baseline and at 1 and 3 months of treatment. Blood viscosity was measured with a viscometer, and shear stress was calculated using a validated formula. Intima-media thickness (IMT) of the carotid artery was detected by ultrasound and was measured with dedicated software. RESULTS: Blood viscosity (4.87 ± 0.57 vs 5.32 ± 0.66 cP, p < 0.02) and shear stress significantly increased in the Empagliflozin group while no change was detected in the Control group (4.66 ± 0.56 vs 4.98 ± 0.73 cP, p = NS). IMT significantly decreased in the Empagliflozin group after 1 and 3 months (baseline: 831 ± 156, 1-month 793 ± 150, 3-month 766 ± 127 μm; p < 0.0001), while in the liraglutide group, IMT significantly decreased only after 3 months (baseline 879 ± 120; 1-month 861 ± 163; 3-month 802 ± 114 μm; p < 0.001). In the sitagliptin group, IMT remained almost unchanged (baseline 901 ± 135; 1-month 902 ± 129; 3-month 880 ± 140 μm; p = NS). CONCLUSIONS: This study is the first to describe a direct effect of empagliflozin on blood viscosity and wall shear stress. Furthermore, IMT was markedly reduced early on in the Empagliflozin group.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12933-018-0695-y

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Common carotid artery peak and mean wall shear stress in the Empagliflozin group (a) and the Control group (b). *p for trend. Bonferroni post hoc analysis: τP baseline vs 1- and 3-month p = 0.03; τM baseline vs 1-month p = 0.04, baseline vs 3-month < 0.01
Fig. 1 Common carotid artery peak and mean wall shear stress in the Empagliflozin group (a) and the Control group (b). *p for trend. Bonferroni post hoc analysis: τP baseline vs 1- and 3-month p = 0.03; τM baseline vs 1-month p = 0.04, baseline vs 3-month < 0.01CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 41 references

Research works printed but not linked: 2

  1. Standard Italiani per la cura del Diabete Mellito 2016. vol. 5, p. 91–117. http://www.standarditaliani.it . Accessed 20 June 2016.
  2. Schou M, Gullestad L, Fitchett D, Zinman B, Inzucchi SE, Hehnke U, von Eynatten M, George J, Johansen OE, Wanner C. Empagliflozin exerts short- and long-term effects on plasma volume in patients with type 2 diabetes: insight from EMPA-REG OUTCOME. Circulation. 2017;136:A15997.

Cited by

See all 75

Metadata

Authors
Irace, C., Casciaro, F., Scavelli, F. B., Oliverio, R., Cutruzzolà, A., Cortese, C., & Gnasso, A.
Affiliations
  • Magna Graecia University (IT)
  • University of Rome Tor Vergata (IT)
Corresponding author
Irace, Concetta
Venue
Cardiovascular Diabetology
Published
2018-04-09
Volume
17
Issue
1
Pages
52-52
ISSN
1475-2840 (ISSN-L)
OpenAlex
W2799739525
Cited by
74
References
42
Citations by year
2026: 7 · 2025: 7 · 2024: 9 · 2023: 14 · 2022: 9 · 2021: 11 · 2020: 5 · 2019: 10 · 2018: 1
FWCI
5.37
Type
journal article
Language
en
Open access
Licence
  • cc-by
  • creativecommons.org/licenses/by/4.0/ (tdm)
Locations
  • Cardiovascular Diabetology (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Hematology › Blood properties and coagulation
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
empagliflozin, blood viscosity, wall shear stress, type 2 diabetes, carotid intima-media thickness, incretin-based therapy, liraglutide, sitagliptin, endothelial function, atherosclerosis, cardioprotection, hematocrit, carotid artery wall thickness, SGLT2 inhibitors
MeSH terms
Sitagliptin Phosphate, Liraglutide, Sodium-Glucose Transporter 2 Inhibitors, Aged, Benzhydryl Compounds, Blood Viscosity, Diabetes Mellitus, Type 2, Female, Glucosides, Humans, Male, Middle Aged, Prospective Studies, Regional Blood Flow, Stress, Mechanical, Time Factors, Treatment Outcome, Carotid Artery, Common, Incretins, Carotid Intima-Media Thickness

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Empagliflozin influences blood viscosity and wall shear stress in subjects with type 2 diabetes mellitus compared with incretin-based therapy. https://app.cochat.ai/papers/10.1186/s12933-018-0695-y
The paper
Irace, C., Casciaro, F., Scavelli, F. B., Oliverio, R., Cutruzzolà, A., Cortese, C., & Gnasso, A. (2018). Empagliflozin influences blood viscosity and wall shear stress in subjects with type 2 diabetes mellitus compared with incretin-based therapy. Cardiovascular Diabetology. https://doi.org/10.1186/s12933-018-0695-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.